Expand ADIL Menu
ADIL MENU

ADIL Latest Press Releases

-- March 6, 2026 --

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- March 3, 2026 --

Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement Globe Newswire 8:17 AM

-- February 24, 2026 --

Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement Globe Newswire 9:00 AM

-- February 23, 2026 --

Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One Globe Newswire 8:30 AM

-- February 17, 2026 --

Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 9:00 AM

-- February 4, 2026 --

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 Globe Newswire 9:35 AM

-- February 3, 2026 --

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement Globe Newswire 4:05 PM

-- January 14, 2026 --

Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045 Globe Newswire 9:00 AM

-- November 26, 2025 --

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds Globe Newswire 8:00 AM

-- November 14, 2025 --

Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 8:30 AM

-- October 17, 2025 --

Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes